Boston Scientific Corp
BSX98.180USD
+0.040+0.04%
Fechamento 09/26, 16:00（ET）Cotações atrasadas em 15 min
145.34BValor de mercado
58.02P/L TTM
Mais detalhes de Empresa
Informações da empresa
Código da empresaBSX
Nome da EmpresaBoston Scientific Corp
Data de listagemMay 19, 1992
CEOMr. Michael F. (Mike) Mahoney
Número de funcionários53000
Tipo de títulosOrdinary Share
Fim do ano fiscalMay 19
Endereço300 Boston Scientific Way
CidadeMARLBOROUGH
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01752-1234
Telefone15086834000
Sitehttps://www.bostonscientific.com/en-US/Home.html
Código da empresaBSX
Data de listagemMay 19, 1992
CEOMr. Michael F. (Mike) Mahoney
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
5.63K
+58.67%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
-58.23%
Mr. Arthur Crosswell Butcher
Mr. Arthur Crosswell Butcher
Executive Vice President, Group President, MedSurg and Asia Pacific
Executive Vice President, Group President, MedSurg and Asia Pacific
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.75M
-3.25%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
+3.95%
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
41.58K
+5.27%
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
37.02K
+5.96%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
35.29K
+1.62%
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
33.45K
+6.64%
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Outro
1.27B
27.32%
Por RegiãoUSD
Nome
Receita
Proporção
United States
2.96B
63.48%
EMEA (Europe, Middle East and Africa)
846.00M
18.14%
Asia Pacific
701.00M
15.03%
Latin America and Canada
155.00M
3.32%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Electrophysiology
730.00M
15.66%
Interventional Cardiology Therapies
697.00M
14.95%
Endoscopy
673.00M
14.43%
Peripheral Interventions
656.00M
14.07%
Urology
633.00M
13.57%
Outro
1.27B
27.32%
Distribuição de ações
Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.21%
Fidelity Management & Research Company LLC
6.71%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.40%
PRIMECAP Management Company
2.34%
Outro
72.06%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.21%
Fidelity Management & Research Company LLC
6.71%
BlackRock Institutional Trust Company, N.A.
5.28%
State Street Global Advisors (US)
4.40%
PRIMECAP Management Company
2.34%
Outro
72.06%
Tipos de investidores
Investidores
Proporção
Investment Advisor
51.04%
Investment Advisor/Hedge Fund
29.03%
Hedge Fund
4.14%
Pension Fund
2.73%
Research Firm
2.53%
Bank and Trust
2.05%
Sovereign Wealth Fund
1.54%
Family Office
0.23%
Private Equity
0.21%
Outro
6.51%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
2752
1.39B
93.57%
+165.36K
2025Q1
2744
1.39B
93.81%
-5.31M
2024Q4
2559
1.38B
93.61%
+1.09M
2024Q3
2417
1.37B
92.76%
-24.32M
2024Q2
2341
1.37B
93.29%
-18.17M
2024Q1
2227
1.37B
93.23%
-40.14M
2023Q4
2171
1.39B
94.95%
-25.34M
2023Q3
2110
1.39B
95.17%
-6.29M
2023Q2
2081
1.38B
95.67%
-15.63M
2023Q1
2012
1.36B
94.85%
-23.81M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
133.95M
9.05%
+1.70M
+1.28%
Mar 31, 2025
Fidelity Management & Research Company LLC
117.45M
7.94%
-3.75M
-3.09%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
77.81M
5.26%
+1.08M
+1.41%
Mar 31, 2025
State Street Global Advisors (US)
64.48M
4.36%
+514.79K
+0.80%
Mar 31, 2025
PRIMECAP Management Company
36.50M
2.47%
-432.72K
-1.17%
Mar 31, 2025
Wellington Management Company, LLP
33.20M
2.24%
-2.97M
-8.21%
Mar 31, 2025
Geode Capital Management, L.L.C.
31.80M
2.15%
+1.18M
+3.84%
Mar 31, 2025
Capital World Investors
28.56M
1.93%
+658.82K
+2.36%
Mar 31, 2025
Managed Account Advisors LLC
21.29M
1.44%
+3.60M
+20.36%
Mar 31, 2025
The Bollard Group, LLC
20.49M
1.39%
-242.40K
-1.17%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: ter, 2 de set
Atualizado em: ter, 2 de set
Nome
Proporção
iShares U.S. Medical Devices ETF
10.54%
Goldman Sachs Future Health Care Equity ETF
8.82%
Invesco Dorsey Wright Healthcare Momentum ETF
4.98%
JPMorgan Healthcare Leaders ETF
4.19%
Global X Aging Population ETF
3.18%
iShares U.S. Healthcare ETF
3.16%
Knowledge Leaders Developed World ETF
3.16%
Proshares Ultra Health Care
3.15%
Bancreek U.S. Large Cap ETF
3.14%
Health Care Select Sector SPDR Fund
3.1%
Ver Mais
iShares U.S. Medical Devices ETF
Proporção10.54%
Goldman Sachs Future Health Care Equity ETF
Proporção8.82%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção4.98%
JPMorgan Healthcare Leaders ETF
Proporção4.19%
Global X Aging Population ETF
Proporção3.18%
iShares U.S. Healthcare ETF
Proporção3.16%
Knowledge Leaders Developed World ETF
Proporção3.16%
Proshares Ultra Health Care
Proporção3.15%
Bancreek U.S. Large Cap ETF
Proporção3.14%
Health Care Select Sector SPDR Fund
Proporção3.1%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
